10.1016/0006-8993(85)91032-7 Summary Keywords Parkinson's disease, cerebrospinal fluid, biological markers, neurotransmitters, oxidative stress, tau protein, alpha-synuclein, beta-amyloid Citation Jimnez-Jimnez FJ, Alonso-Navarro H, Garca-Martn E and Agndez JAG (2014) Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease
To this day, several clinical trials are ongoing in a large panel of age-related diseases, but their validation remains uncertain (Table 1)
Ph hp vi mi loi da, nam v n u c th s dng
Mitochondria and coenzyme Q10 in the pathogenesis of preeclampsia
Because it avoids those receptors, AOD 9604 does not elevate IGF-1 levels, does not affect blood sugar regulation, and does not carry the risks associated with exogenous growth hormone use